How many drugs treat Myoclonic seizure?

Drug Landscape tracks 3 marketed treatments for Myoclonic seizure (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/myoclonic-seizure.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Myoclonic seizure — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Myoclonic seizure (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Myoclonic seizure, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Ativan	lorazepam	Generic (originally Wyeth/Pfizer)	Benzodiazepine [EPC]	GABA-A receptor alpha-1/beta-3/gamma-2, Fatty acid-binding protein, liver	1977-09-30
Klonopin	clonazepam	Generic (originally Roche)	Benzodiazepine [EPC]	GABA-A receptor alpha-1/beta-2/gamma-2, GABA-A receptor; anion channel, GABA-A receptor; anion channel	1975-06-04
Klonopin	Klonopin	Par Pharmaceutical, Inc.		GABA-A receptor alpha-1/beta-2/gamma-2, GABA-A receptor; anion channel, GABA-A receptor; anion channel

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Myoclonic seizure
Generic (originally Roche) · 1 drug in Myoclonic seizure
Generic (originally Wyeth/Pfizer) · 1 drug in Myoclonic seizure
Par Pharmaceutical, Inc. · 1 drug in Myoclonic seizure

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Myoclonic seizure:

Cite this brief

Drug Landscape (2026). Myoclonic seizure — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/myoclonic-seizure. Accessed 2026-06-10.

Myoclonic seizure full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing